System and Method for Optimizing Insulin Dosages for Diabetic Subjects
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 25 of these applications claim priority to application 61/934,300, filed Jan 31, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,483,619 | Means and Method For Improved Glycemic Control For Diabetic Patients In force · High confidence | Glytec, LLC | In force | High confidence | ||
| US 9,773,096 | Means and Method For Improved Glycemic Control For Diabetic Patients In force · Medium confidence | Glytec, LLC | In force | Medium confidence | ||
| US 9,811,638 | Means and Method For Improved Glycemic Control For Diabetic Patients In force · Medium confidence | Glytec, LLC | In force | Medium confidence | ||
| US 9,965,596 | Means and Method for Improved Glycemic Control for Diabetic Patients In force · Medium confidence | Glytec, LLC | In force | Medium confidence | ||
| US 10,102,922 | Means and Method For Improved Glycemic Control For Diabetic Patients In force · Medium confidence | Glytec, LLC | In force | Medium confidence | ||
| US 10,410,740 | Means and Method for Improved Glycemic Control for Diabetic Patients In force · Medium confidence | Glytec, LLC | In force | Medium confidence | ||
| US 10,629,294 | Means and Method for Improved Glycemic Control for Diabetic Patients In force · Medium confidence | Glytec, LLC | In force | Medium confidence | ||
| US 11,131,643 | Method and System for Optimizing Insulin Dosages for Diabetic Subjects In force · High confidence | Glytec, LLC | In force | High confidence | ||
| US 11,733,196 | System and Method for Optimizing Insulin Dosages for Diabetic Subjects In force · High confidence | Glytec, LLC | In force | High confidence | ||
| US 9,171,343 | Means and Method for Improved Glycemic Control for Diabetic Patients In force · High confidence | Glytec, LLC | In force | High confidence | ||
| 52 more patents in this group · Pro | ||||||
10 of 62 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 62.
52 of these are in force and held by Glytec, LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.